CERO THERAPEUTICS HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 45.76 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- CERO THERAPEUTICS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 45.76M shares, a 11163.88% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- CERO THERAPEUTICS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- CERO THERAPEUTICS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 70.90K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 5 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 45.76M shares 10-Q · filed 2026-08-14 | 45.76M shares derived: sum of 3 quarters · filed 2026-08-14 | 45.76M shares derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | 45.76M shares 10-Q · filed 2026-05-15 | 45.76M shares derived: sum of 2 quarters · filed 2026-05-15 | 45.76M shares derived: sum of 3 quarters · filed 2026-05-15 | 45.42M shares derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-04-15 | -335.35K shares derived: sum of 3 quarters · filed 2026-04-15 | 70.90K shares 10-K · filed 2026-04-15 | |||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -335.35K shares derived: sum of 2 quarters · filed 2025-11-19 | 70.90K shares 10-Q · filed 2025-11-19 | ||||
| 2025-06-30 | -335.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-22 | 70.90K shares 10-Q · filed 2025-08-22 | |||||
| 2025-03-31 | 406.25K shares 10-Q · filed 2025-05-15 | ||||||
| 2024-09-30 | 5.04M shares 10-Q/A · filed 2024-11-20 | ||||||
| 2024-06-30 | 5.04M shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 4.62M shares 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |